Psychiatr Pol 2002 Nov-Dec;36(6 Suppl):133-41
I Klinika Psychiatryczna Katedry Psychiatrii AM w Lodzi.
Based on a literature review, the application of Acetylocholinesterase inhibitors, IAchE (donepezil, rivastigmine, galantanine) in the treatment of various illnesses which have cholinergic system disability and dementia in their course--(dementia with Lewy bodies, vascular dementia, Parkinson's disease, Multiple Sclerosis, Down Syndrome), delirium symptoms (e.g. Korsakov psychosis), hyperkinesis, attention and memory disorders--is presented.
Promising results in the treatment of late dyskinesias, in schizophrenia with impaired cognitive function, as well as in the additional treatment of various psychotic states are noted.
It should be stressed that in Poland, the IAchE have been approved only in the treatment of slight to moderate dementia in the course of Alzheimer's disease.